These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Processa Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy and ...

Investing.com — Processa Pharmaceuticals Inc. (PCSA)股价已跌至52周低点，触及0.22美元。这一显著下跌反映了公司正经历艰难时期，该股票一年内下跌了85.8%。根据 InvestingPro 数据显示，公司市值已萎缩至仅124万美元，而技术指标表明该股票处于超卖区域。投资者目睹了公司市值在过去一年中的急剧下降，因为该股票在市场压力和行业特定逆风中 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Respected Sir/Madam,This is to inform you that pursuant to regulation 30 read with Part A of Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Akums Drugs & ...

Anurag Mantri has been roped in as the President at Glenmark Pharmaceuticals, the company stated in a regulatory filing. His new role is effective from today, April 7, 2025. Mantri joins from ...

Recursion Pharmaceuticals witnessed a 27% decline in market value over the last week, a period marked by significant Executive and Board changes. The company appointed Dr. Namandjé Bumpus and Elaine ...